SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuit, Inc. engages in the provision of business and financial management solutions. It operates through the following segments: Small Business and Self-Employed, Consumer, Credit Karma, and ProTax. The Small Business and Self-Employed segment offers QuickBooks financial and business management online services and desktop software, payroll solutions, payment processing solutions, and financing for small businesses. The Consumer segment includes do-it-yourself and assisted TurboTax income tax preparation products and services. The Credit Karma segment serves consumers with a personal finance platform that provides personalized recommendations of credit cards, home, auto and personal loans, and insurance products, and online savings and checking accounts. The ProTax segment refers to the professional accountants in the U.S. and Canada, who are essential to both small business success and tax preparation and filing. The company was founded by Scott D. Cook and Thomas A. Proulx in March 1983 and is headquartered in Mountain View, CA.

Intuit Inc

Intuit's latest report triggered a sharp post-print selloff after the company included share-based compensation in its guidance and pointed to slowing growth, fueling a split between traders calling it an AI disruption warning and those seeing an overreaction and buying opportunity.

Dick's Sporting Goods, Inc. engages in the retailing of an extensive assortment of authentic sports equipment, apparel, footwear, and accessories. It also offers its products both online and through mobile applications. The company was founded by Richard T. Stack in 1948 and is headquartered in Coraopolis, PA.

Dicks Sporting Goods, Inc.

DKS shares are getting wrecked after a headline miss and slashed full-year outlook, with the community heavily blaming the Foot Locker acquisition for dragging on results. Trader chatter is split between those calling it an overreaction and oversold buy opportunity versus those saying further weakness could stack up, while many keep referencing the three-day rule and waiting for the selling to exhaust before stepping in.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

CRML is ripping on surging volume as traders hype a potential short squeeze amid a broad rare-earth sector rally, with CEO Tony Sage's media presence and Greenland Tanbreez progress fueling bullish sentiment. The community is split between aggressive squeeze calls and deep skepticism over management's missteps and contested project economics, but the prevailing momentum narrative is drawing heavy FOMO.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Zoom is trending amid a post-earnings selloff, with traders split on the double beat and raised full-year outlook versus a softer quarterly profit forecast and the broader software shakeout. Community debate is focused on whether the weakness is overdone, with Anthropic exposure and buybacks noted as offsets, or a reminder that Zoom remains a pandemic-era name losing relevance.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors discuss potential catalysts surrounding the company's cancer-treatment pipeline, including a teased trial involving targeted radiation and an IL-15-based treatment. Community sentiment remains mixed, with intense debate over the stock's long-term potential, management's communication style, and the regulatory challenges faced by the company's flagship drug, Anktiva.

On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, all-day activities, and tennis. It sells its products worldwide through independent retailers and global distributors, its own online presence, and its own stores. The company was founded by David Allemann, Olivier Bernhard, and Caspar Coppetti in January 2010 and is headquartered in Zurich, Switzerland.

On Holding AG - Ordinary Shares Class A

On Holding AG

On Holding is trending after its post-earnings crash to 52-week lows on a revenue miss and guidance cut, with the apparel and footwear sector also dragged by weak results from Dick's Sporting Goods. The community is split between calling the drop an overreaction and citing strong DTC growth and heavy insider buying, while others warn of continued downside.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng's weak Q2 report and softer guidance initially drew heavy criticism, but the blowout $900 million funding round for its robotics unit at a $6.3 billion valuation with Tencent and Alibaba backing has pivoted the conversation to whether the stock should be valued as an EV maker or as a physical-AI platform. The community remains split between believers loading up on the robotics thesis and skeptics focused on lagging profitability and a weak auto outlook.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is catching fire as the U.S. Treasury's expanded long-end bond buybacks trigger intense debate over market intervention, with bulls chanting "don't fight the Treasury" while skeptics like Druckenmiller call it a policy mistake. Community conversation is centered on whether this is stealth QE, financial repression, and a potential short squeeze in long bonds.

Subsquid Network is an innovative decentralized data lake and query engine designed to offer developers performant and permissionless access to data, aiming to build a neutral and open internet rooted in Web3 principles. Secured by ZK proofs, the Subsquid network boasts a modular architecture that enables exceptional scalability and developer convenience optimized for blockchain indexing, dApp development, and analytics.  Subsquid is a response to unscalable and rigid monolithic indexing frameworks that had previously gained popularity and market traction among Web3 developers. Today, these frameworks are struggling to adapt in a rapidly evolving blockchain environment. Additionally, the network serves as a highly efficient and decentralized alternative to centralized infrastructure firms, including large RPC and API providers.

Traders are focused on SQD's newly confirmed Google connection and what that means for Rezolve's broader enterprise adoption story, with many calling it a core piece of future Web3 data infrastructure. Community chatter is heavy on network growth, institutional validation, and speculation about additional major partnerships ahead.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Psychedelic-sector momentum, a highly regarded new CEO hire, and growing speculation around the completed Phase 3 enrollment and upcoming Q4 topline for HLP003 have traders piling into this breakout move. The community is comparing the valuation to larger peers like CMPS and DFTX and debating buyout possibilities versus dilution risk, with most attention on an expected binary catalyst ahead.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Arrived Homes 4 LLC. - Ordinary Share (Ser Jennie)

Neutral Sentiment

Rallies more than 5%

Modest gain (0-5%)

Modest decline (0-5%)

Drops more than 5%

Nvidia ($NVDA) reports earnings Wednesday, August 26, with options markets pricing in a roughly 5-7% post-earnings move. How do you think Nvidia's stock reacts to earnings? Vote and explain your reasoning in the comments.

Nvidia ($NVDA) reports earnings Wednesday, with options markets pricing in a 5-7% move. How do you think the stock reacts?

Stocktwits

) reports earnings Wednesday, with options markets pricing in a 5-7% move. How do you think the stock reacts?

Feed

News

Sentiment

Fundamentals

Info